J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM

Watchlist Manager
J B Chemicals and Pharmaceuticals Ltd Logo
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Watchlist
Price: 1 623.2 INR 0.46%
Market Cap: 252.7B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+33%
Revenue
Forecast
+14%
Operating Income
Forecast
+19%
Net Income
Forecast
+20%

Wall Street
Price Targets

JBCHEPHARM Price Targets Summary
J B Chemicals and Pharmaceuticals Ltd

Wall Street analysts forecast JBCHEPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JBCHEPHARM is 2 159.71 INR with a low forecast of 1 702.86 INR and a high forecast of 2 568.3 INR.

JBCHEPHARM Lowest Forecast
Wall Street Target
1 702.86 INR
5% Upside
JBCHEPHARM Average Forecast
Wall Street Target
2 159.71 INR
33% Upside
JBCHEPHARM Highest Forecast
Wall Street Target
2 568.3 INR
58% Upside
Lowest
Price Target
1 702.86 INR
5% Upside
Average
Price Target
2 159.71 INR
33% Upside
Highest
Price Target
2 568.3 INR
58% Upside
J B Chemicals and Pharmaceuticals Ltd Competitors:
Price Targets
B
300558
Betta Pharmaceuticals Co Ltd
11% Upside
300725
PharmaBlock Sciences Nanjing Inc
14% Upside
AXSM
Axsome Therapeutics Inc
52% Upside
603998
Hunan Fangsheng Pharmaceutical Co Ltd
47% Upside
B
300558
Betta Pharmaceuticals Co Ltd
11% Upside
300725
PharmaBlock Sciences Nanjing Inc
14% Upside
AXSM
Axsome Therapeutics Inc
52% Upside
603998
Hunan Fangsheng Pharmaceutical Co Ltd
47% Upside

Revenue
Forecast

Revenue Estimate
J B Chemicals and Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's revenue is 14%. The projected CAGR for the next 3 years is 14%.

14%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
J B Chemicals and Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's operating income is 20%. The projected CAGR for the next 3 years is 19%.

20%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
J B Chemicals and Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's net income is 17%. The projected CAGR for the next 3 years is 20%.

17%
Past Growth
20%
Estimated Growth
Estimates Accuracy
5%
Average Beat
What are analyst estimates?

See Also

Summary
JBCHEPHARM intrinsic value, competitors valuation, and company profile.
DCF Valuation
JBCHEPHARM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
JBCHEPHARM stock valuation using valuation multiples.
Wall Street Estimates
JBCHEPHARM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
JBCHEPHARM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JBCHEPHARM's stock price target?
Price Target
2 159.71 INR

According to Wall Street analysts, the average 1-year price target for JBCHEPHARM is 2 159.71 INR with a low forecast of 1 702.86 INR and a high forecast of 2 568.3 INR.

What is J B Chemicals and Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's revenue is 14%. The projected CAGR for the next 3 years is 14%.

What is J B Chemicals and Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's operating income is 20%. The projected CAGR for the next 3 years is 19%.

What is J B Chemicals and Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's net income is 17%. The projected CAGR for the next 3 years is 20%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.